Caffeine reduces the activation extent and contrast-to-noise ratio of the functional cerebral blood flow response but not the BOLD response

NeuroImage

Volumn 42, Issue 1, 2008, Pages 296-305

  Liau, Joy ^a,b   Perthen, Joanna E ^a   Liu, Thomas T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; CONTRAST TO NOISE RATIO; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; NEUROMODULATION; NOISE STANDARD; NORMAL HUMAN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SIGNAL PROCESSING; TREATMENT PLANNING;

ADULT; BRAIN; CAFFEINE; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; OXYGEN CONSUMPTION;

EID: 45849140096     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.04.177     Document Type: Article

References (39)

1. Aguirre G.K., Zarahn E., and D'Esposito M. The variability of human, BOLD hemodynamic responses. NeuroImage 8 (1998) 360-369
2. Aguirre G.K., Detre J.A., Zarahn E., and Alsop D.C. Experimental design and the relative sensitivity of BOLD and perfusion fMRI. NeuroImage 15 (2002) 488-500
3. Behzadi Y., and Liu T.T. Caffeine reduces the initial dip in the visual BOLD response at 3 T. NeuroImage 32 1 (2006) 9-15
4. Boynton G.M., Engel S.A., Glover G.H., and Heeger D.J. Linear systems analysis of functional magnetic resonance imaging in human V1. J. Neuroscience 16 (1996) 4207-4221
5. Buxton R.B., Uludag K., Dubowitz D.J., and Liu T.T. Modeling the hemodynamic response to brain activation. Neuroimage 23 Suppl 1 (2004) S220-S233
6. Chen Y., and Parrish T.B. Activation induced BOLD and CBF responses vary with with caffeine dose. Proceedings of the 15th ISMRM Scientific Meeting, Berlin (2007) 112
7. Cohen E.R., Ugurbil K., and Kim S.G. Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. J. Cereb. Blood Flow Metab. 22 9 (2002) 1042-1053
8. Cox R.W. AFNI-software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 29 (1996) 162-173
9. Davis C.E., Jeste D.V., and Eyler L.T. Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia. Schizophr. Res. 78 1 (2005) 45-60
10. Fredholm B.B., Battig K., Holmen J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 1 (1999) 83-133
11. Haacke E.M., Hu C., Parrish T.B., and Xu Y. Whole brain stress test using caffeine: effects on fMRI and SWI at 3T. Proceedings of the ISMRM 11th Scientific Meeting (2003) 1731
12. Haberg A., Kvistad K.A., Unsgard G., and Haraldseth O. Preoperative blood oxygen level-dependent functional magnetic resonance imaging in patients with primary brain tumors: clinical application and outcome. Neurosurgery 54 4 (2004) 902-914 discussion 914-5
13. Kastrup A., Li T.Q., Kruger G., Glover G.H., and Moseley M.E. Relationship between cerebral blood flow changes during visual stimulation and baseline flow levels investigated with functional MRI. NeuroReport 10 8 (1999) 1751-1756
14. Kemna L.J., Posse S., Tellmann L., Schmitz T., and Herzog H. Interdependence of regional and global cerebral blood flow during visual stimulation: an O-15-butanol positron emission tomography study. J. Cereb. Blood Flow Metab. 21 6 (2001) 664-670
15. Lassen N.A. Cerebral blood flow and oxygen consumption in man. Physiol. Rev. 39 2 (1959) 183-238
16. Laurienti P.J., Field A.S., Burdette J.H., Maldjian J.A., Yen Y.-F., and Moody D.M. Dietary caffeine consumption modulates fMRI measures. NeuroImage 17 (2002) 751-757
17. Li T.Q., Kastrup A., Moseley M.E., and Glover G.H. Changes in baseline cerebral blood flow in humans do not influence regional cerebral blood flow response to photic stimulation. J. Magn. Reson. Imaging 12 5 (2000) 757-762
18. Liu T.T., and Wong E.C. A signal processing model for arterial spin labeling functional MRI. NeuroImage 24 1 (2005) 207-215
19. Liu T.T., Frank L.R., Wong E.C., and Buxton R.B. Detection power, estimation efficiency, and predictability in event-related fMRI. NeuroImage 13 4 (2001) 759-773
20. Liu T.T., Behzadi Y., Restom K., Uludag K., Lu K., Buracas G.T., Dubowitz D.J., and Buxton R.B. Caffeine alters the temporal dynamics of the visual BOLD response. NeuroImage 23 4 (2004) 1402-1413
21. Lu H., Clingman C., Golay X., and van Zijl P.C. Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn. Reson. Med. 52 3 (2004) 679-682
22. Luh W.M., Wong E.C., Bandettini P.A., Ward B.D., and Hyde J.S. Comparison of simultaneously measured perfusion and BOLD signal increases during brain activation with T(1)-based tissue identification. Magn. Reson. Med. 44 1 (2000) 137-143
23. Melamed E., Lavy S., Bentin S., Cooper G., and Rinot Y. Reduction in regional cerebral blood flow during normal aging in man. Stroke 11 1 (1980) 31-35
24. Mulderink T.A., Gitelman D.R., Mesulam M.-M., and Parrish T.B. On the use of caffeine as a contrast booster for BOLD fMRI studies. NeuroImage 15 (2002) 37-44
25. Mumford J.A., Hernandez-Garcia L., Lee G.R., and Nichols T.E. Estimation efficiency and statistical power in arterial spin labeling fMRI. NeuroImage 33 1 (2006) 103-114
26. Olson I.R., Rao H., Moore K.S., Wang J., Detre J.A., and Aguirre G.K. Using perfusion fMRI to measure continuous changes in neural activity with learning. Brain Cogn. 60 3 (2006) 262-271
27. Perthen J.E., Lansing A.E., Liau J., Liu T.T., and Buxton R.B. Caffeine-induced uncoupling of cerebral blood flow and oxygen metabolism: a calibrated BOLD fMRI study. NeuroImage 40 1 (2008) 237-247
28. Restom K., Behzadi Y., and Liu T.T. Physiological noise reduction for arterial spin labeling functional MRI. NeuroImage 31 3 (2006) 1104-1115
29. Seber G.A.F., and Lee A.J. Linear Regression Analysis (2003), John Wiley & Sons, New York
30. Shimosegawa E., et al. Photic stimulation study of changing the arterial partial pressure level of carbon dioxide. J. Cereb. Blood Flow Metab. 15 1 (1995) 111-114
31. St Lawrence K.S., and Wang J. Effects of the apparent transverse relaxation time on cerebral blood flow measurements obtained by arterial spin labeling. Magn. Reson. Med. 53 2 (2005) 425-433
32. St Lawrence K.S., Ye F.Q., Lewis B.K., Frank J.A., and McLaughlin A.C. Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation. Magn. Reson. Med. 50 1 (2003) 99-106
33. Stefanovic B., Warnking J.M., Rylander K.M., and Pike G.B. The effect of global cerebral vasodilation on focal activation hemodynamics. NeuroImage 30 3 (2006) 726-734
34. Tjandra T., Brooks J.C., Figueiredo P., Wise R., Matthews P.M., and Tracey I. Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: Implications for clinical trial design. NeuroImage (2005)
35. Wang J., Aguirre G.K., Kimberg D.Y., Roc A.C., Li L., and Detre J.A. Arterial spin labeling perfusion fMRI with very low task frequency. Magn. Reson. Med. 49 (2003) 796-802
36. Wang J., Qiu M., and Constable R.T. In vivo method for correcting transmit/receive nonuniformities with phased array coils. Magn. Reson. Med. 53 3 (2005) 666-674
37. Wong E.C., Buxton R.B., and Frank L.R. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn. Reson. Med. 39 5 (1998) 702-708
38. Woolrich M.W., Ripley B.D., Brady M., and Smith S.M. Temporal autocorrelation in univariate linear modeling of fMRI data. NeuroImage 14 6 (2001) 1370-1386
39. Yang L.L., Peiffer A.M., Addicott M.A., Kraft R.A., Maldjian J.A., Burdette J.H., Burnett L.R., Chen M.Y., and Laurienti P.J. BOLD signal decreases following caffeine challenge in individuals who intake high daily doses of caffeine. Proceedings of the 13th Human Brain Mapping, Chicago (2007) 396M